University of Crete (UOC)
Χρήση ινωδολυτικών ουσιών στη θεραπεία των επιπλεγμένων υπεζωκοτικών συλλογών και του εμπυήματος
Abstract
dc:descriptionTHE SCOPE OF THE STUDY WAS TO INVESTIGATE THE EFFICACY, SAFETY AND COST OF INTRAPLEURAL ADMINISTRATION OF FIBRINOLYTICS (SK AND UK), USED AS AMADJUNT TO CHEST TUBE DRUNAGE IN THE MANAGMENT OF CPE AND PLEURAL EMPYEMA (PE), COMPARES THEM AND VERITY IF THEY ACT PHARMACOLOGICAL OR MECHANICAL (VOLUME-EFFECT). THEREFORE WE DESIGN 4 PROTOCOLLS WITH THE SAME INELUSION AND EXCLUSION CRITERIA AND THE SAME METHOD FRASSESMENT. PROTOCOL NO1: PROSPECTIVE STUDY 20 PTS WITH INTRAPLEURAL SK, NO2: PROSPECTIVE STUDY 20 PTS WITH UK, NO3: PROSPECTIVE, DOUBLE-BLIND, RANDOMIZED STUDY 50 PTS COMPARES THE TWO FIBRINOLYTICS, NO4: PROSPECTIVE, RANDOMIZED DOUBLE-BLIND STUDY 31 PTS IN TERMS OF EFFECTIVENESS AND ROLE OF THE INSTILLED VOLUME. IN CONCLUSION INTRAPLEURAL FIBRINOLYTICS (SK ANDUK) IS AN SAFE AND EFFECTIVE ADJUNCT IN THE MANAGEMENT OF PARAPNEUMONIC EFFUSIONS AND MY REDUSE THE NEED, FOR SURGERY FIBRINOLYTICS IS EFFECTIVE IN THE TREATMENT OF CPE AND PE THROUGH THE LYSIS OF THE PLEURAL ADHESIONS AND NOT DUETO VOLUME EFFECT. UK COULD BE THE FIBRINOLYTIC OF CHOISE GIVEN THE POTENTIALLY DANGEROUS ALLERGIC REACTIONS TO SK AND RELATIVELY LITTLE HIGHER COST OF UK.
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 1998
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Σχίζα, Σοφία
Subjects
dc:subject × 16Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/11350